Explore the Global PARP Inhibitor Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

PARP Inhibitor Market

Key Insight

The PARP inhibitor market was valued at USD 6.8 billion in 2025, is projected to reach USD 17.0 billion by 2036 and is forecast to register an 8.7% CAGR between 2026 and 2036. In 2026, olaparib holds 86.2% of drug type sales and ovarian cancer represents 83.9% within the indication segment.

May 19, 2026

Anurag Sharma

324 Pages

Cite this Report

PARP Inhibitor Market

https://www.futuremarketinsights.com/reports/parp-inhibitors-market

License

Buy Now

Summary ToC Companies

Key Players

AstraZeneca
Astellas Pharma Inc
BlackRock
GSK plc
IMPACT Therapeutics
Janssen Biotech Inc
Johnson & Johnson Innovative Medicine
Merck KGaA
The Vanguard Group
Software as a Service Platforms
Specialty Asset Owners

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

PARP Inhibitor Market

Key Players

Similar Industry Reports